Aster DM Healthcare Schedules Q3FY26 Earnings Conference Call for February 02, 2026
Aster DM Healthcare has scheduled its Q3FY26 earnings conference call for February 02, 2026, at 11:00 AM IST to discuss unaudited financial results for the quarter and nine months ended December 31, 2025. The call will feature senior management including Chairman & Managing Director Dr. Azad Moopen, Deputy Managing Director Ms. Alisha Moopen, and other key executives. The announcement was made in compliance with SEBI Regulation 30 requirements, with registration details provided for analysts and investors.

*this image is generated using AI for illustrative purposes only.
Aster DM Healthcare has formally announced its earnings conference call scheduled for February 02, 2026, at 11:00 AM IST to discuss the company's unaudited financial results for the quarter and nine months ended December 31, 2025. The announcement was communicated to both BSE Limited and the National Stock Exchange of India Ltd on January 27, 2026, in compliance with regulatory requirements.
Regulatory Compliance and Communication
The earnings call announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Hemish Purushottam signed the official communication, ensuring proper adherence to disclosure norms for listed companies.
Management Participation
The Q3FY26 earnings conference call will feature comprehensive representation from Aster DM Healthcare 's senior management team. The following executives will participate in the call:
| Position: | Name |
|---|---|
| Chairman & Managing Director: | Dr. Azad Moopen |
| Deputy Managing Director: | Ms. Alisha Moopen |
| Non-Executive Director: | Mr. T J Wilson |
| Chief Operating Officer: | Mr. Ramesh Kumar S |
| Chief Financial Officer: | Mr. Sunil Kumar M R |
| Chief Investor Relations & M&A Officer: | Mr. Hitesh Dhaddha |
Call Details and Access Information
The earnings conference call is specifically designed for analysts and investors to gain insights into the company's financial performance for Q3FY26. The call will provide detailed discussions on the unaudited financial results covering both quarterly and nine-month periods ended December 31, 2025.
| Event Details: | Information |
|---|---|
| Date: | Monday, February 02, 2026 |
| Time: | 11:00 AM IST |
| Purpose: | Q3FY26 Financial Results Discussion |
| Reporting Period: | Quarter and nine months ended December 31, 2025 |
Corporate Information
Aster DM Healthcare operates from multiple locations with its registered office located at No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Hyderabad, Ameerpet, Telangana, India - 500038. The company's corporate office is situated at Awfis, 2nd Floor, Renaissance Centra, 27 & 27/1, Mission Road, Sampangi Rama Nagar, Bengaluru, Karnataka, India - 560027.
For additional clarification regarding the earnings call, interested parties can reach out via email to investors@asterdmhealthcare.in . The company has established this dedicated communication channel to address investor queries and provide necessary support for call participation.
Historical Stock Returns for Aster DM Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.42% | -6.97% | -6.65% | -6.83% | +11.61% | +260.56% |


































